Your browser doesn't support javascript.
loading
Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support.
Gyoten, Takayuki; Amiya, Eisuke; Saito, Akihito; Ono, Minoru.
Afiliación
  • Gyoten T; Department of Cardiac Surgery, The University of Tokyo, Tokyo, Japan.
  • Amiya E; Department of Cardiovascular Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
  • Saito A; Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
  • Ono M; Department of Therapeutic Strategy for Heart Failure, The University of Tokyo, Tokyo, Japan.
Article en En | MEDLINE | ID: mdl-38830049
ABSTRACT

OBJECTIVES:

Predictors and evaluations of continuous flow left ventricular assist device (cf-LVAD) explantation in recovered patients remain under discussion due to lack of evidence on long-term safety and efficacy. This study summarized our experiences regarding cf-LVAD explantation in non-ischaemic dilated cardiomyopathy patients and estimated a predictor for sufficient myocardial recovery allowing left ventricular assist device explant.

METHODS:

We retrospectively identified 135 adult patients with cf-LVAD therapy as bridge to heart transplant due to non-ischaemic dilated cardiomyopathy. Of those, 13 patients underwent device explantation (recovery group) after myocardial recovery. Twelve (92%) of the explanted patients were evaluated using our weaning protocol and underwent surgical explantation. Meanwhile, the remaining 122 continued with cf-LVAD therapy (non-recovery group).

RESULTS:

Multivariate logistic regression analysis revealed time interval between the first heart failure event and cf-LVAD implantation as an independent predictor for successful explantation. The optimal time interval cutoff value to predict cf-LVAD explantation was 7 months, with a sensitivity of 91.0% and specificity of 84.6%. Echocardiography in patients with successful cf-LVAD explantation showed significant improvement of left ventricular function and dimensions at 6 months postoperatively. The 13 explanted patients are currently alive at a median of 30 (interquartile range; 18-58) months after explantation. The survival rate free from rehospitalization due to heart failure following explantation was 100%. Left ventricular function and remodelling after explantation were also preserved.

CONCLUSIONS:

In non-ischaemic dilated cardiomyopathy patients with a short interval between the first heart failure event and cf-LVAD therapy, left ventricular myocardium may recover in an early phase after device implantation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Interdiscip Cardiovasc Thorac Surg Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Interdiscip Cardiovasc Thorac Surg Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido